Article
SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by…
bioRxiv: the preprint server for biology · 2020 · Alan C-Y. Hsu, author Guoqiang Wang, author Andrew T. Reid, author Punnam Chander. Veerati, author Prabuddha S. Pathinayake, author Katie Daly, author Jemma R. Mayall, author Philip M. Hansbro, author Jay C. Horvat, author Fang Wang, author Peter A. Wark, author
Key facts
| Title | SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro |
|---|---|
| First author | Alan C-Y. Hsu, author Guoqiang Wang, author Andrew T. Reid, author Punnam Chander. Veerati, author Prabuddha S. Pathinayake, author Katie Daly, author Jemma R. Mayall, author Philip M. Hansbro, author Jay C. Horvat, author Fang Wang, author Peter A. Wark, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Oct 11, 2020 |
| DOI | 10.1101/2020.09.30.317818 |
| Devices mentioned | BK110039 |
| Product codes mentioned | JJH, KIT, NDS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1